ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has approved an increase in price of medicines and life-saving drugs across the country.
In a statement issued on Thursday, the authority notified an increase of nine per cent in the retail price of life-saving drugs, while prices of other medicines will go up by 15 per cent.
The decision, according to the DRAP notification, has been approved by the federal government.
“Maximum retail prices of drugs may be increased under paragraph 12 (8) of the Drug Pricing Policy, 2018,” reads the notification. “Nine per cent over and above the maximum retail prices as determined under hardship category during the year 2018, and 15 per cent over and above the existing maximum retail prices determined under the Drug Pricing Policy, 2018 for drugs other than those specified in Clause (a).”
DRAP has directed for the revised prices to be printed on labels in the manner prescribed under the Drugs (Labeling and Packaging) Rules, 1986.
“The manufacturers and importers of drugs shall furnish calculations of revised maximum retail prices of drugs to the Division of Costing and Pricing of DRAP before implementing the increase.”